Beta is a financial metric that shows how much a stock’s price moves compared to the overall stock market. A beta of 1 means the stock generally moves in line with the market. If a stock has a beta below 1, it tends to be less volatile, while a beta above 1 suggests it is more volatile than the market average.

For investors, choosing low-beta stocks can be a smart strategy to reduce risk and limit exposure to big market swings. Such stocks may provide better stability during downturns and help safeguard portfolios, while still offering the potential for steady long-term growth.

Listed below are such small stocks that have a beta of less than 1: 

J B Chemicals & Pharmaceuticals Limited

With a market capitalization of Rs. 26,543.06 crore, the shares of J B Chemicals & Pharmaceuticals Limited were currently trading at Rs. 1,695 per equity share, down nearly 0.70 percent from its previous day’s close price of Rs. 1,706.95. 

The stock carries a one-year beta of 0.52, indicating lower volatility compared to the broader market. The company’s ROCE and ROE stand at 25.8 percent and 20.1 percent, respectively. J B Chemicals & Pharmaceuticals Limited also reports an earnings per share (EPS) of Rs. 44, with a debt-to-equity ratio of 0.01x, reflecting its financial position.

J B Chemicals & Pharmaceuticals Limited was established in 1976 by founder J.B. Mody. The company manufactures and markets various pharmaceutical products, including tablets, capsules, injections, creams, and medicines for both domestic and international healthcare markets across multiple countries globally.

Coming into financial highlights, J B Chemicals & Pharmaceuticals Limited’s revenue has increased from Rs. 1,004 crore in Q1 FY25 to Rs. 1,094 crore in Q1 FY26, which has grown by 8.96 percent. The net profit has also grown by 14.12 percent from Rs. 177 crore in Q1 FY25 to Rs. 202 crore in Q1 FY26.

Navin Fluorine International Limited

With a market capitalization of Rs. 24,473.54 crore, the shares of Navin Fluorine International Limited were currently trading at Rs. 4,777.90 per equity share, rising nearly 0.35 percent from its previous day’s close price of Rs. 4,761.20. 

The stock carries a one-year beta of 0.66, indicating lower volatility compared to the broader market. The company’s ROCE and ROE stand at 11.7 percent and 11.5 percent, respectively. Navin Fluorine International Limited also reports an earnings per share (EPS) of Rs. 71.5, with a debt-to-equity ratio of 0.56x, reflecting its financial position.

Navin Fluorine International Limited was established in 1967. The company manufactures specialty fluorochemicals, including refrigeration gases, inorganic fluorides, and organofluorides, while providing contract research and manufacturing services for pharmaceuticals, agrochemicals, and specialty chemical industries.

Coming into financial highlights, Navin Fluorine International Limited’s revenue has increased from Rs. 524 crore in Q1 FY25 to Rs. 725 crore in Q1 FY26, which has grown by 38.36 percent. The net profit has also grown by 129.41 percent from Rs. 51 crore in Q1 FY25 to Rs. 117 crore in Q1 FY26.

Alembic Pharmaceuticals Limited

With a market capitalization of Rs. 18,584.06 crore, the shares of Alembic Pharmaceuticals Limited were currently trading at Rs. 945.45 per equity share, down nearly 0.10 percent from its previous day’s close price of Rs. 946.40. 

The stock carries a one-year beta of 0.32, indicating lower volatility compared to the broader market. The company’s ROCE and ROE stand at 13 percent and 11.4 percent, respectively. Alembic Pharmaceuticals Limited also reports an earnings per share (EPS) of Rs. 30.7, with a debt-to-equity ratio of 0.24x, reflecting its financial position.

Alembic Pharmaceuticals Limited was established in 1907 as Alembic Chemical Works Company Ltd. The company manufactures and markets pharmaceutical products, including tablets, capsules, injections, vitamins, antibiotics, and generic formulations for domestic and international markets, serving over 75 countries.

Coming into financial highlights, Alembic Pharmaceuticals Limited’s revenue has increased from Rs. 1,562 crore in Q1 FY25 to Rs. 1,711 crore in Q1 FY26, which has grown by 9.54 percent. The net profit has also grown by 14.07 percent from Rs. 135 crore in Q1 FY25 to Rs. 154 crore in Q1 FY26.

Hatsun Agro Product Limited

With a market capitalization of Rs. 20,162.06 crore, the shares of Hatsun Agro Product Limited were currently trading at Rs. 905.15 per equity share, rising nearly 0.57 percent from its previous day’s close price of Rs. 910.30. 

The stock carries a one-year beta of 0.42, indicating lower volatility compared to the broader market. The company’s ROCE and ROE stand at 13.1 percent and 17 percent, respectively. Hatsun Agro Product Limited also reports an earnings per share (EPS) of Rs. 13.6, with a debt-to-equity ratio of 1.49x, reflecting its financial position.

Hatsun Agro Product Limited was established in 1970 by R.G. Chandramogan. The company manufactures and markets dairy products, including milk, curd, ice cream, paneer, ghee, and dairy whitener under brands like Arun, Arokya, and Hatsun for domestic and international markets.

Coming into financial highlights, Hatsun Agro Product Limited’s revenue has increased from Rs. 2,375 crore in Q1 FY25 to Rs. 2,535 crore in Q1 FY26, which has grown by 6.74 percent. The net profit has also grown by 12.98 percent from Rs. 131 crore in Q1 FY25 to Rs. 148 crore in Q1 FY26.

Shriram Pistons & Rings Limited

With a market capitalization of Rs. 11,470.79 crore, the shares of Shriram Pistons & Rings Limited were currently trading at Rs. 2,604.05 per equity share, down nearly 0.28 percent from its previous day’s close price of Rs. 2,611.40. 

The stock carries a one-year beta of 0.31, indicating lower volatility compared to the broader market. The company’s ROCE and ROE stand at 25.7 percent and 23.2 percent, respectively. Shriram Pistons & Rings Limited also reports an earnings per share (EPS) of Rs. 119, with a debt-to-equity ratio of 0.21x, reflecting its financial position.

Shriram Pistons & Rings Limited was established in 1963, renamed in 1972. The company manufactures engine components, including pistons, piston rings, engine valves, and pins for the automotive industry, serving Original Equipment Manufacturers (OEMs) both domestically and internationally across multiple vehicle segments.

Coming into financial highlights, Shriram Pistons & Rings Limited’s revenue has increased from Rs. 837 crore in Q1 FY25 to Rs. 963 crore in Q1 FY26, which has grown by 15.05 percent. The net profit has also grown by 15.38 percent from Rs. 117 crore in Q1 FY25 to Rs. 135 crore in Q1 FY26.

Written By – Nikhil Naik

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.